NOS3 and metabolic syndrome: Importantly, the endothelial specific thrombo-regulators and inhibitors of platelets reactivity endothelial nitric oxide synthase eNOS or NOS3 (p = 0.0249) and the inducible iNOS or NOS2 (p = 0.0319) are noticeably decreased in MetS as well.